Immunohematology Market by Product (Analyzer, Reagent), Technology (Biochips, Gel Cards, Microplates, PCR, Erythrocyte-Magnetized), End-User (Hospitals, Diagnostic Laboratories, Blood Banks), & Region for 2024-2031

Immunohematology Market Valuation – 2024-2031

The expanding frequency of chronic diseases, as well as the necessity for safe and effective blood transfusions, are driving the immunohematology market forward. According to the analyst from Market Research, the immunohematology market is estimated to reach a valuation of USD 12.67 Billion by 2031 over the forecast subjugating around USD 6.55 Billion in 2024.

The increased use of automated and advanced immunohematology analyzers and reagents to improve the efficiency and accuracy of blood typing and cross-matching is another important driver of the immunohematology market. It enables the market to grow at a CAGR of 10.11% from 2024 to 2031.

Immunohematology MarketDefinition/ Overview

Immunohematology is the study of blood antigens and antibodies, as well as their applications in transfusion medicine and blood diseases. Immunohematologists, often known as blood bankers, are in charge of blood type, cross-matching, and antibody identification to assure the safety and effectiveness of blood transfusions. Immunohematology also studies stem cell therapies, regenerative medicine, and cellular therapeutics. Immunohematologists offer specialist advice on complex transfusion cases, mass transfusions, and the use of specialized blood products such as irradiation or leukoreduced blood.

What are the Key Factors Driving the Growth of the Immunohematology Market?

The increasing number of surgical procedures, trauma cases, and chronic conditions that necessitate blood transfusions is a major driver of the immunohematology market. According to the World Health Organization (WHO), over 118.5 million blood donations are collected globally each year. According to the American Red Cross, roughly 29,000 units of red blood cells are required daily in the United States. Demand for blood products is predicted to rise by 1-3% each year in affluent countries, necessitating better immunohematology testing.

Furthermore, the increasing prevalence of blood illnesses is driving up demand for immunohematology diagnostics. According to the Leukemia & Lymphoma Society, in the United States, one person is diagnosed with blood cancer every three minutes. In 2020, around 178,520 persons in the United States were diagnosed with leukemia, lymphoma, or myeloma. The International Agency for Research on Cancer predicts that the global incidence of leukemia will rise by 62% between 2018 and 2040. This expanding patient group demands sophisticated immunohematology testing to ensure proper diagnosis and therapy.

What are the Challenges Hindering the Demand of Immunohematology?

Specialized knowledge and expertise are required for accurately interpreting immunohematology test results and managing complex transfusion cases. However, there is a dearth of skilled workers in some areas, limiting the use of sophisticated immunohematology methods and technologies.

Furthermore, the adoption of immunohematology solutions is hampered by the expensive cost of modern analyzers, automation systems, and specialist reagents, particularly in resource-constrained environments. Smaller laboratories and hospitals face a challenge in investing in cutting-edge blood typing and compatibility testing equipment.

Category-Wise Acumens

How is the Demand for Immunohematology Reagents Increasing in the Market?

According to analysis, the reagent segment is estimated to hold the largest market share in the product segment during the forecast period. The rising need for immunohematology testing in blood banks is a major driver of the reagents market. Reagents are required to perform numerous blood types, antibody screening, and compatibility testing, all of which are vital to guarantee the safety of blood transfusions.

The demand for customized reagents to satisfy specific testing criteria is growing as healthcare professionals seek more personalized and precise immunohematology treatments. This tendency is driving up demand for specialist reagents, contributing to the segment’s growth.

Furthermore, the integration of immunohematology reagents with advanced diagnostic technologies, such as automated analyzers and molecular testing platforms, is accelerating their use. These integrated solutions increase efficiency, accuracy, and turnaround times, making them more appealing to healthcare providers.

How Does Gel Card Technology Support the Growing Demand in the Market?

The gel card technology segment is estimated to dominate the immunohematology market during the forecast period. Gel cards provide a user-friendly and automated platform for blood type and antibody screening, making them ideal for both small and big laboratories. Their broad acceptance is due to their ability to process several samples at the same time, as well as the availability of ready-to-use reagents.

The gel card method yields highly accurate and sensitive results in immunohematology testing, detecting even weak antibodies. This high degree of performance is critical for providing safe and effective blood transfusions, resulting in increased demand for gel card-based systems.

Furthermore, gel card-based analyzers are intended to be compatible with existing laboratory infrastructure, allowing for seamless integration into existing workflows. This interoperability, combined with the availability of a large range of reagents and accessories, makes gel card technology an appealing solution for many healthcare facilities.

Gain Access into Immunohematology Market Report Methodology

Country/Region-wise Acumens

How Does Strong Focus on Research & Development in North America Impacting the Market?

According to analyst, North America is estimated to dominate the Immunohematology Market during the forecast period. North America, particularly the United States, has a high frequency of chronic disorders that frequently necessitate blood transfusions, which fuels the immunohematology market. The American Cancer Society estimates that in 2021, there will be 1.9 million new cancer cases identified in the United States. The National Heart, Lung, and Blood Institute estimates approximately 100,000 persons in the United States have sickle cell disease. These disorders frequently require blood transfusions, demanding extensive immunohematology testing. According to the American Red Cross, someone in the United States needs blood every two seconds, resulting in a daily requirement of around 36,000 units of red blood cells.

North America’s advanced healthcare infrastructure and high healthcare spending have a substantial impact on the immunohematology market. The Centers for Medicare and Medicaid Services estimate that healthcare spending in the United States exceeded USD 4.1 Trillion in 2020, or $12,530 per person. This significant investment enables the use of modern immunohematology technologies. The United States Department of Health and Human Services states that there are over 6,000 hospitals in the country, many of which include cutting-edge immunohematology laboratories.

Furthermore, the expanding geriatric population in North America is a major driver of the immunohematology market, as older people are more likely to require blood transfusions and are more susceptible to blood illnesses. According to the United States Census Bureau, the number of Americans aged 65 and up is expected to nearly double, from 52 million in 2018 to 95 million by 2060. According to the American Society of Hematology, the incidence of myelodysplastic syndromes, a group of blood disorders common in older adults, is estimated to be 4.9 cases per 100,000 people per year in the United States, with the incidence increasing to 22.8 cases per 100,000 people per year in those aged 70 and older.

What are the Main Drivers of the Immunohematology Market in Asia Pacific?

The Asia Pacific region is estimated to exhibit the highest growth during the forecast period. The Asia Pacific region is experiencing an increase in blood disorders and chronic diseases that necessitate regular blood transfusions, driving up demand for immunohematology treatments. According to the World Health Organization’s Western Pacific Region office, thalassemia is a major public health concern in the region, with 5-10% of the population in some nations harboring the thalassemia gene. Over 100,000 new instances of severe thalassemia are diagnosed annually in Southeast Asia, necessitating regular blood transfusions and immunohematology testing.

Rapid economic expansion in several Asia Pacific countries has resulted in higher healthcare spending and improved medical infrastructure, hence driving the immunohematology market. According to the India Brand Equity Foundation, the Indian healthcare sector is predicted to grow at a CAGR of 22% between 2016 and 2022, reaching USD 372 Billion. This increase includes large investments in blood banks and transfusion services, which have a direct impact on the immunohematology market.

Furthermore, the Asia Pacific region is experiencing an increase in emphasis on blood safety and quality control measures, which is pushing the adoption of modern immunohematology procedures. According to the World Health Organization, the percentage of voluntary non-remunerated blood donations in Southeast Asia rose from 78% in 2013 to 90% by 2018. This shift toward safer blood donation procedures has increased the requirement for advanced immunohematology testing to ensure transfusion safety.

Competitive Landscape

The immunohematology market is highly competitive, with both major and small firms. The market is characterized by fierce competition among the leading players, who are constantly investing in product innovation, strategic alliances, and mergers and acquisitions to obtain a competitive advantage.

Some of the prominent players operating in the immunohematology market include

• Grifols S.A.
• Immucor, Inc.
• Thermo Fisher Scientific
• Merck KGaA
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Becton Dickinson and Company
• Beckman Coulter, Inc.
• Siemens Healthineers
• Ortho Clinical Diagnostics
• Cardinal Health
• Hoffmann La-Roche Ltd.
• DIAGAST
• MTC INVITRO
• Seqirus
• Institut de Biotechnologies Jacques Boy
• Hemo bioscience

Latest Developments

• In April 2022, Sysmex Europe introduced the XQ-320 XQ-Series Automated Hematology Analyzer, a new three-part differential system with improved performance and efficiency for small-to-medium-sized laboratories. The new analyzer aims to boost workflow and productivity in immunohematology testing.

Report Scope

Immunohematology Market, By Category

Product

• Analyzer
• Reagent

Technology

• Biochips
• Gel Cards
• Microplates
• PCR
• Erythrocyte-Magnetized Technology

End-User

• Hospitals
• Diagnostic Laboratories
• Blood Banks

Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the Market based on segmentation involving both economic as well as non-economic factors• Provision of Market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as dominate the Market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the Market within each region• Competitive landscape which incorporates the Market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major Market players• The current as well as the future Market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the Market from various perspectives through Porter’s five forces analysis• Provides insight into the Market through Value Chain• Market dynamics scenario, along with growth opportunities of the Market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.